Nasus Pharma Reveals Promising Phase 2 Study Results for FMXIN002, a Novel Intranasal Epinephrine Powder #Israel #Tel_Aviv #Nasus_Pharma #FMXIN002 #Anaphylaxis
0
0
0
0
Nasus Pharma Reveals Promising Phase 2 Study Results for FMXIN002, a Novel Intranasal Epinephrine Powder #Israel #Tel_Aviv #Nasus_Pharma #FMXIN002 #Anaphylaxis
Nasus Pharma to Showcase Promising Clinical Findings on FMXIN002 at AAAAI 2025 #Israel #Tel_Aviv #Allergy_Treatment #Nasus_Pharma #FMXIN002